Status:
COMPLETED
SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir)
Lead Sponsor:
University of Zurich
Conditions:
SARS-CoV 2
COVID
Eligibility:
All Genders
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the current pandemic of coronavirus disease (COVID-19) that can lead to respiratory failure requiring oxygen therapy. Some ...
Detailed Description
Study aims: * To evaluate subjective and objective recovery after discharge from hospital in patients with respiratory failure due to COVID-19. * To identify risk factors for COVID-19 associated resp...
Eligibility Criteria
Inclusion
- hospitalization at University Hospital Zurich due to COVID-19 infection
- hospital discharge max. 4 weeks ago
- requiring supplemental oxygen
Exclusion
- \<18 years
- non-German speaking
- no smartphone access
Key Trial Info
Start Date :
June 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 17 2021
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04365595
Start Date
June 3 2020
End Date
February 17 2021
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091